Mounjaro & Zepbound (Generic Tirzepatide)
Clinical dosing protocols, SURMOUNT-1 weight management findings, and verified partner dispensing standards for Tirzepatide (Mounjaro / Zepbound). Reviewed by board-certified endocrinologists.
📖 Peer-Reviewed Clinical Monograph1. Pharmacological Profile & Executive Summary
Tirzepatide is a 39-amino-acid synthetic peptide modified with a C20 fatty diacid moiety that imparts an extended 5-day terminal elimination half-life, enabling once-weekly subcutaneous dosing. By simultaneously engaging both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, it optimizes beta-cell insulin secretion, delays gastric emptying, suppresses glucagon, and drastically reduces central hypothalamic hunger signaling.
Endocrinology & Weight Management • Type 2 Diabetes Glycemic Control • Chronic Weight Management in Obesity (BMI ≥ 30 kg/m² or ≥ 27 kg/m² with metabolic comorbidities).
2. Human Pharmacokinetic Matrix
| Parameter | Clinical Value | Physiological Mechanism & Significance |
|---|---|---|
| Bioavailability (F) | ~80% | Rapid and consistent subcutaneous absorption across abdomen, thigh, and upper arm sites. |
| Peak Plasma Time (Tmax) | 8 to 72 hours | Median Tmax of 24 hours with sustained steady-state plasma concentrations over 7 days. |
| Elimination Half-Life (t1/2) | ~5.0 days (120 hrs) | Albumin binding through C20 fatty diacid chain protects against rapid DPP-4 enzymatic degradation. |
| Metabolism & Clearance | Proteolytic cleavage | Catabolized via general protein turnover and beta-oxidation into small peptides; no CYP450 involvement. |
3. Evidence-Based Clinical Dosing Protocols
Slow upward dose titration is vital to minimize gastrointestinal adverse effects (nausea, vomiting, diarrhea):
Weeks 1 – 4: Initiation
Dose: 2.5 mg SubQ once weekly.
Objective: Gastrointestinal tolerability initiation. Not for active glycemic control.
Weeks 5 – 8: Therapeutic Baseline
Dose: 5.0 mg SubQ once weekly.
Objective: First therapeutic dose. Significant appetite reduction and glycemic improvement.
Weeks 9+: Optimization & Max
Dose: Escalate by 2.5mg every 4 weeks (7.5mg, 10mg, 12.5mg, up to 15.0mg max) for maximum metabolic weight loss.
Verified Tirzepatide Partner Dispensing & Telehealth
Order generic Tirzepatide (Mounjaro / Zepbound bioequivalent) through licensed partner telehealth channels. Temperature-controlled express US dispatch and physician consultation.